The effect of the GM-CSF/IL-3 fusion protein PIXY321 on bone marrow and circulating haemopoietic cells of previously untreated patients with cancer

British Journal of Haematology

Volumn 93, Issue 1, 1996, Pages 6-12

  Ghielmini, Michele ^a   Pettengell, Ruth ^b   Coutinho, Lucia H ^b   Testa, Nydia ^b   Crowther, Derek ^b  

^a Department of Radiotherapy   (Switzerland)

^b NONE

Author keywords

cytokinase; mobilization; phase I; PIXY321; progenitor cells

Indexed keywords

CYTOKINE; HYBRID PROTEIN; INTERLEUKIN 3; MILODISTIM;

ADULT; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; ERYTHEMA; FEMALE; HEADACHE; HEMATOPOIESIS; HUMAN; MALE; MUSCLE WEAKNESS; PAIN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; CELL COUNT; CELL MOVEMENT; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HODGKIN DISEASE; HUMANS; INTERLEUKIN-3; LEUKOCYTE COUNT; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; PLATELET COUNT; RECOMBINANT FUSION PROTEINS;

EID: 0029940636     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.4731015.x     Document Type: Article

References (30)

1. Bishop, M.R., Anderson, J.R., Jackson, J.D., Bierman, P.J., Reed, E.C., Vose, J.M., Armitage, J.O., Warkentin, P.J. & Kessinger, A. (1994) High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood, 83, 610-616.
2. Briddell, R.A., Brandt, J.E., Leemhuis, T.B. & Hoffman, R. (1992) Role of cytokines in sustaining long-term human megakaryocytopoiesis in vitro. Blood, 79, 332-337.
3. Broxmeyer, H.E., Williams, D.E., Hangoc, G., Cooper, S., Gillis, S., Shadduck, R.K. & Bicknell, D. (1987) Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1, recombinant murine interleukin 3, and recombinant murine granulocyte/macrophage colony-stimulating factor. Proceedings of the National Academy of Sciences of the United States of America, 84, 3871-3875.
4. Brugger, W., Bross, K.J., Lindemann, A., Kanz, L. & Mertelsmann, R. (1992a) Role of hematopoietic growth factor combinations in experimental and clinical oncology. Seminars in Oncology, 19, (Suppl. 4), 8-15.
5. Brugger, W., Frisch, J., Schulz, G., Pressler, K., Mertelsmann, R. & Kanz, L. (1992b) Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following standard-dose combination chemotherapy with etoposide, ifosfamide, and cisplatin. Journal of Clinical Oncology, 10, 1452-1459.
6. Bruno, E., Briddell, R.A., Cooper, R.J., Brandt, J.E. & Hoffman, R. (1992) Recombinant GM-CSF/IL-3 fusion protein: its effect on in vitro human megakaryocytopoiesis. Experimental Hematology, 20, 494-499.
7. Bruno, E., Briddell, R.A. & Hoffman, R. (1988) Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation. Experimental Hematology, 16, 371-377.
8. Coutinho, L.H., Gilleece, M.H., De Wynter, E.A., Will, A. & Testa, N.G. (1993) Clonal and long-term cultures using human bone marrow. Haemopoiesis: a Practical Approach (ed. by N. G. Testa and G. Molineux), p. 75. Oxford University Press, New York.
9. Curtis, B.M., Williams, D.E., Broxmeyer, H.E., Dunn, J., Farrah, T., Jeffery, E., Clevenger, W., De Roos, P., Martin, U., Friend, D., Craig, V., Gayle, R., Price, V., Cosman, D., March, C.J. & Park, L.S. (1991) Enhanced hematopoietic activity of a human granulocyte macrophage colony-stimulating factor-interleukin 3 fusion protein. Proceedings of the National Academy of Sciences of the United States of America, 88, 5809-5813.
10. DeLuca, E., Sheridan, W.P., Watson, D., Szer, J. & Begley, C.G. (1992) Prior chemotherapy does not prevent effective mobilization by G-CSF of peripheral blood progenitor cells. British Journal of Cancer, 66, 893-899.
11. D'Hondt, V., Weynants, P., Humblet, Y., Guillaume, T., Canon, J.L., Beauduin, M., Duprez, P., Longueville, J., Müll, R., Chatelain, C. & Symann, M. (1993) Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib study. Journal of Clinical Oncology, 11, 2063-2071.
12. Donahue, R.E., Seehra, J., Metzger, M., Lefebvre, D., Rock, B., Carbone, S., Nathan, D.G., Garnick, M., Sehgal, P.K., Laston, D., La Vallie, E., McCoy, J., Schendel, P.F., Norton, C., Turner, K., Yang, Y.C. & Clark, S.C. (1988) Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science, 241, 1820-1822.
13. Ganser, A., Lindemann, A., Ottmann, O.G., Seipelt, G., Hess, U., Geissler, G., Kanz, L., Frisch, J., Schulz, G., Herrmann, F., Mertelsmann, R. & Hoelzer, D. (1992) Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study. Blood, 79, 2583-2591.
14. Ganser, A., Lindemann, A., Seipelt, G., Ottmann, O.G., Herrmann, F., Eder, M., Frisch, J., Schulz, G., Mertelsmann, R. & Hoelzer, D. (1990) Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood, 76, 666-676.
15. Geissler, K., Valent, P., Mayer, P., Liehl, E., Hinterberger, W., Lechner, K. & Bettelheim, P. (1990) Recombinant human interleukin-3 expands the pool of circulating hematopoietic progenitor cells in primates: synergism with recombinant human granulocyte/macrophage colony-stimulating factor. Blood, 75, 2305-2310.
16. Gianni, A.M., Bregni, M., Stern, A.C., Bonadonna, G., Siena, S., Tarella, C. & Pileri, A. (1989) Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet, 9, 580-584.
17. Ho, A.D., Haas, R., Koerbling, M., Dietz, M. & Hunstein, W. (1991) Utilization of recombinant human GM-CSF to enhance peripheral progenitor cell yield for autologous transplantation. Bone Marrow Transplantation, 7, (Suppl. 1), 13-17.
18. Ottmann, O.G., Ganser, A., Seipelt, G., Eder, M., Schulz, G. & Hoelzer, D. (1990) Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo. Blood, 76, 1494-1502.
19. Pettengell, R., Morgenstern, G.R., Woll, P.J., Chang, J., Rowlands, M., Young, R., Radford, J.A., Scarffe, J.H., Testa, N.G. & Crowther, D. (1993a) Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood, 82, 3770-3777.
20. Pettengell, R., Testa, N.G., Swindell, R., Crowther, D. & Dexter, T.M. (1993b) Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood, 82, 2239-2248.
21. Schwinger, W., Mache, C.H., Urban, C., Beaufort, F. & Töglhofer, W. (1993) Single dose of filgrastim (rhG-CSF) increases the number of hematopoietic progenitors in the peripheral blood of adult volunteers. Bone Marrow Transplantation, 11, 489-492.
22. Sheridan, W.P., Begley, C.G., Juttner, C.A., Szer, J., To, L.B., Maher, D., McGrath, K.M., Morstyn, G. & Fox, R.M. (1992) Effect of peripheral-blood progenitor cells mobilised by lilgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet, 339, 640-644.
23. Siena, S., Bregni, M., Bonsi, L., Sklenar, I., Bagnara, G.P., Bonadonna, G. & Gianni, A.M. (1993) Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors. Experimental Hematology, 21, 1583-1590.
24. Siena, S., Bregni, M., Brando, B., Belli, N., Ravagnani, F., Gandola, L., Stern, A.C., Lansdorp, P.M., Bonadonna, G. & Gianni, A.M. (1991) Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood, 77, 400-409.
25. Stahl, C.P., Winton, E.F., Monroe, M.C., Haff, E., Holman, R.C., Myers, L., Liehl, E. & Evatt, B.L. (1992) Differential effects of sequential, simultaneous, and single agent interleukin-3 and granulocyte-macrophage colony-stimulating factor on megakaryocyte maturation and platelet response in primates. Blood, 80, 2479-2485.
26. Taketazu, F., Chiba, S., Shibuya, K., Kuwaki, T., Tsumura, H., Miyazono, K., Miyagawa, K. & Takaku, F. (1991) IL-3 specifically inhibits GM-CSF binding to the higher affinity receptor. Journal of Cellular Physiology, 146, 251-257.
27. To, L.B., Roberts, M.M., Haylock, D.N., Dyson, P.G., Branford, A.L., Thorp, D., Ho, J.Q.K., Dart, G.W., Horvath, N., Davy, M.L.J., Olweny, C.L.M., Abdy, E. & Juttner, C.A. (1992) Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplantation, 9, 277-284.
28. Vadhan-Raj, S., Papadopoulos, N.E., Burgess, M.A., Linke, K.A., Patel, S.R., Hays, C., Arcenas, A., Plager, C., Kudelka, A.P., Hittelman, W.N., Broxmeyer, H.E., Williams, D.E., Garrison, L. & Benjamin, R.S. (1994) Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma. Journal of Clinical Oncology, 12, 715-724.
29. Villeval, J.L., Duehrsen, U., Morstyn, G. & Metcalf, D. (1990) Effect of recombinant human granulocyte-macrophage colony stimulating factor on progenitor cells in patients with advanced malignancies. British Journal of Haematology, 74, 36-44.
30. Williams, D.E. & Park, L.S. (1991) Hematopoietic effects of a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein. Cancer, 67, 2705-2707.